ABBV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.25%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $130,442,034.24

AbbVie Insider Trading History Chart

AbbVie Share Price & Price History

^$175.58

▲ +4.06 (2.37%)

As of 12/20/2024 06:45 PM ET

Days: 30 | 90 | 365

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Click here now for the urgent details.

AbbVie Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/16/2024	Kevin K Buckbee	SVP	Sell	1,800	$172.24	$310,032.00	6,983
8/5/2024	Richard A. Gonzalez	Chairman	Sell	66,500	$186.52	$12,403,580.00	446,599
7/17/2024	Richard A. Gonzalez	Chairman	Sell	282,845	$175.00	$49,497,875.00	513,099
3/20/2024	Nicholas Donoghoe	EVP	Sell	21,082	$176.30	$3,716,756.60	55,903
3/18/2024	Jeffrey Ryan Stewart	EVP	Sell	58,949	$178.79	$10,539,491.71	60,941
2/29/2024	Kevin K Buckbee	SVP	Sell	5,144	$176.65	$908,687.60	6,983
2/29/2024	Perry C Siatis	EVP	Sell	9,891	$177.39	$1,754,564.49	10,397
2/29/2024	Robert A. Michael	COO	Sell	68,879	$176.45	$12,153,699.55	98,645
2/28/2024	Richard A. Gonzalez	CEO	Sell	138,616	$177.27	$24,572,458.32	519,099
2/23/2024	Perry C Siatis	EVP	Sell	13,753	$177.51	$2,441,295.03	28,173
2/23/2024	Scott T. Reents	CFO	Sell	14,140	$177.44	$2,509,001.60	27,065
2/21/2024	Azita Saleki-Gerhardt	EVP	Sell	52,870	$173.71	$9,184,047.70	243,944
12/26/2023	Nicholas Donoghoe	EVP	Sell	2,912	$154.72	$450,544.64	55,903
7/31/2023	Richard A. Gonzalez	CEO	Sell	18,500	$149.15	$2,759,275.00	625,294
4/25/2023	Elaine K. Sorg	SVP	Sell	6,130	$165.00	$1,011,450.00	35,330
4/17/2023	Elaine K. Sorg	SVP	Sell	7,499	$161.67	$1,212,363.33	35,330
4/3/2023	Elaine K. Sorg	SVP	Sell	15,002	$160.03	$2,400,770.06	42,829
4/3/2023	Perry C Siatis	EVP	Sell	3,520	$160.00	$563,200.00	10,377
3/13/2023	Jeffrey Ryan Stewart	EVP	Sell	53,125	$152.28	$8,089,875.00	60,941
3/1/2023	Elaine K. Sorg	SVP	Sell	15,003	$155.00	$2,325,465.00	42,829
3/1/2023	Perry C Siatis	EVP	Sell	12,135	$153.08	$1,857,625.80	10,377
3/1/2023	Scott T. Reents	CFO	Sell	15,942	$153.08	$2,440,401.36	809
2/21/2023	Carrie C. Strom	SVP	Sell	28,541	$151.04	$4,310,832.64	37,921
2/17/2023	Azita Saleki-Gerhardt	EVP	Sell	25,000	$149.53	$3,738,250.00	233,208
2/17/2023	Roxanne S. Austin	Director	Sell	10,000	$150.50	$1,505,000.00	40,705
12/12/2022	Timothy J. Richmond	EVP	Sell	42,370	$163.44	$6,924,952.80	13,837
5/23/2022	Michael Severino	Vice Chairman	Sell	79,801	$150.90	$12,041,970.90	152,103
5/16/2022	Henry O Gosebruch	EVP	Sell	83,960	$155.00	$13,013,800.00	16,623
5/16/2022	Michael Severino	Vice Chairman	Sell	100,000	$154.45	$15,445,000.00	152,103
5/9/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.28	$15,028,000.00	152,103
5/6/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.81	$15,081,000.00	152,103
3/24/2022	Jeffrey Ryan Stewart	EVP	Sell	27,690	$159.20	$4,408,248.00
3/9/2022	Brian L. Durkin	VP	Sell	18,628	$150.01	$2,794,386.28
3/1/2022	Henry O Gosebruch	EVP	Sell	15,000	$148.26	$2,223,900.00
3/1/2022	Robert A. Michael	Vice Chairman	Sell	43,105	$148.25	$6,390,316.25
2/7/2022	Carrie C. Strom	SVP	Sell	2,396	$141.17	$338,243.32

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.

SEC Filings (Institutional Ownership Changes) for AbbVie (NYSE:ABBV)

70.23% of AbbVie stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbbVie Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/13/2024	Lord Abbett & CO. LLC	1,634,739	$322.83M	1.0%	-8.0%	0.093%
12/13/2024	B. Riley Wealth Advisors Inc.	86,100	$16.94M	0.5%	-22.5%	0.005%
12/12/2024	Legacy Wealth Management LLC MS	1,623	$0.32M	0.1%	N/A	0.000%
12/11/2024	1ST Source Bank	28,489	$5.63M	0.3%	-1.1%	0.002%
12/10/2024	Birmingham Capital Management Co. Inc. AL	30,622	$6.05M	2.2%	+3.0%	0.002%
12/10/2024	DGS Capital Management LLC	3,361	$0.66M	0.2%	+12.4%	0.000%
12/9/2024	Copley Financial Group Inc.	2,475	$0.49M	0.4%	N/A	0.000%
12/6/2024	Logan Capital Management Inc.	110,516	$21.83M	0.9%	+0.2%	0.006%
12/6/2024	Fidelity D & D Bancorp Inc.	2,999	$0.59M	0.4%	-11.3%	0.000%
12/6/2024	Retirement Systems of Alabama	901,128	$177.96M	0.7%	-5.7%	0.051%
12/3/2024	Oddo BHF Asset Management Sas	24,146	$4.77M	0.2%	N/A	0.001%
12/2/2024	Capasso Planning Partners LLC	11,242	$2.22M	0.7%	-15.3%	0.001%
12/2/2024	Beaird Harris Wealth Management LLC	2,732	$0.54M	0.0%	+32.8%	0.000%
11/29/2024	American Trust	6,691	$1.32M	0.1%	+3.4%	0.000%
11/29/2024	Old North State Trust LLC	7,432	$1.47M	1.2%	+1.3%	0.000%
11/27/2024	Franklin Resources Inc.	13,873,744	$2.73B	0.8%	-13.0%	0.785%
11/26/2024	Asset Advisors Investment Management LLC	97,323	$19.22M	2.0%	-0.5%	0.006%
11/26/2024	Peapack Gladstone Financial Corp	209,463	$41.36M	0.6%	+5.4%	0.012%
11/25/2024	Synovus Financial Corp	129,684	$25.61M	0.3%	-1.0%	0.007%
11/25/2024	Tidal Investments LLC	113,375	$22.39M	0.2%	+0.7%	0.006%
11/25/2024	Destination Wealth Management	3,369	$0.67M	0.0%	+68.1%	0.000%
11/25/2024	Wilmington Savings Fund Society FSB	82,223	$16.24M	0.3%	+157.0%	0.005%
11/25/2024	Arvest Bank Trust Division	91,224	$18.02M	1.0%	N/A	0.005%
11/25/2024	World Investment Advisors LLC	48,390	$9.56M	0.2%	-7.2%	0.003%
11/25/2024	Sanctuary Advisors LLC	528,802	$104.43M	0.7%	+23.7%	0.030%
11/25/2024	Pine Valley Investments Ltd Liability Co	60,787	$12M	0.7%	+12.6%	0.003%
11/22/2024	Stock Yards Bank & Trust Co.	75,015	$14.81M	0.5%	-1.9%	0.004%
11/22/2024	Fulcrum Equity Management	7,205	$1.42M	1.2%	-10.7%	0.000%
11/21/2024	Anchor Investment Management LLC	88,716	$17.52M	1.7%	+2.9%	0.005%
11/21/2024	Tudor Financial Inc.	2,253	$0.45M	0.3%	N/A	0.000%
11/21/2024	Te Ahumairangi Investment Management Ltd	22,062	$4.33M	0.8%	-0.4%	0.001%
11/21/2024	Wealthquest Corp	2,766	$0.55M	0.0%	-55.8%	0.000%
11/21/2024	Aldebaran Financial Inc.	2,360	$0.47M	0.6%	N/A	0.000%
11/20/2024	Morse Asset Management Inc	7,563	$1.49M	0.3%	+2.4%	0.000%
11/20/2024	Diamant Asset Management Inc.	18,480	$3.65M	2.3%	-0.5%	0.001%
11/20/2024	Westside Investment Management Inc.	17,296	$3.40M	0.7%	+1.0%	0.001%
11/20/2024	Bard Financial Services Inc.	69,255	$13.68M	1.6%	-7.4%	0.004%
11/19/2024	McIlrath & Eck LLC	826	$0.16M	0.0%	-15.6%	0.000%
11/19/2024	Invst LLC	3,900	$0.77M	0.1%	-5.6%	0.000%
11/19/2024	Citizens Business Bank	31,779	$6.28M	1.3%	-2.4%	0.002%
11/19/2024	Unigestion Holding SA	79,527	$15.70M	0.8%	-24.0%	0.005%
11/19/2024	Second Line Capital LLC	1,918	$0.38M	0.1%	N/A	0.000%
11/19/2024	TCW Group Inc.	403,638	$79.71M	0.7%	+0.5%	0.023%
11/19/2024	Hohimer Wealth Management LLC	1,432	$0.28M	0.1%	+12.6%	0.000%
11/18/2024	Soltis Investment Advisors LLC	47,458	$9.37M	0.9%	-1.6%	0.003%
11/18/2024	Rehmann Capital Advisory Group	13,867	$2.74M	0.2%	-2.7%	0.001%
11/18/2024	TD Private Client Wealth LLC	70,411	$13.91M	0.4%	-0.4%	0.004%
11/18/2024	Virtue Capital Management LLC	4,756	$0.94M	0.2%	-6.2%	0.000%
11/18/2024	Fortem Financial Group LLC	8,509	$1.68M	0.7%	+19.1%	0.000%
11/18/2024	Arete Wealth Advisors LLC	24,786	$4.89M	0.4%	N/A	0.001%
11/18/2024	Teachers Retirement System of The State of Kentucky	273,650	$54.04M	0.5%	-2.8%	0.015%
11/18/2024	Sunbelt Securities Inc.	46,611	$9.21M	0.9%	-2.9%	0.003%
11/18/2024	Toronto Dominion Bank	697,877	$137.82M	0.2%	-25.9%	0.039%
11/18/2024	Empire Financial Management Company LLC	11,870	$2.34M	0.7%	-0.8%	0.001%
11/18/2024	Chiron Investment Management LLC	10,752	$2.12M	0.7%	N/A	0.001%
11/18/2024	Brown Financial Advisors	2,474	$0.49M	0.2%	-41.4%	0.000%
11/18/2024	Coldstream Capital Management Inc.	62,071	$12.19M	0.3%	+5.8%	0.004%
11/18/2024	Strait & Sound Wealth Management LLC	9,859	$1.95M	0.9%	+1.4%	0.001%
11/18/2024	Orion Capital Management LLC	3,855	$0.76M	0.4%	+2.4%	0.000%
11/18/2024	First Dallas Securities Inc.	17,625	$3.48M	1.5%	-5.1%	0.001%
11/18/2024	Ashford Capital Management Inc.	5,390	$1.06M	0.1%	+35.4%	0.000%
11/16/2024	Geode Capital Management LLC	36,161,045	$7.12B	0.6%	-1.4%	2.046%
11/15/2024	MidWestOne Financial Group Inc.	36,748	$7.26M	1.0%	-0.2%	0.002%
11/15/2024	Goodman Advisory Group LLC	15,534	$3.07M	0.9%	+11.6%	0.001%
11/15/2024	Greenwood Gearhart Inc.	1,090	$0.22M	0.0%	N/A	0.000%
11/15/2024	3Chopt Investment Partners LLC	13,368	$2.64M	0.9%	+2.6%	0.001%
11/15/2024	Frisch Financial Group Inc.	7,730	$1.53M	0.5%	+11.7%	0.000%
11/15/2024	Prestige Wealth Management Group LLC	4,123	$0.81M	0.2%	+10.3%	0.000%
11/15/2024	Brophy Wealth Management LLC	1,047	$0.21M	0.1%	N/A	0.000%
11/15/2024	Resources Management Corp CT ADV	80,810	$15.96M	2.2%	-0.7%	0.005%
11/15/2024	Executive Wealth Management LLC	2,903	$0.57M	0.0%	+2.8%	0.000%
11/15/2024	Guardian Wealth Management Inc.	27,910	$5.51M	3.9%	+1.5%	0.002%
11/15/2024	Abel Hall LLC	2,434	$0.48M	0.3%	+3.7%	0.000%
11/15/2024	Continuum Advisory LLC	14,309	$2.83M	0.4%	+4.4%	0.001%
11/15/2024	O Brien Greene & Co. Inc	10,865	$2.15M	0.7%	-11.4%	0.001%
11/15/2024	LRI Investments LLC	13,975	$2.76M	0.2%	+51.0%	0.001%
11/15/2024	PYA Waltman Capital LLC	18,051	$3.57M	1.2%	+4.9%	0.001%
11/15/2024	Peloton Wealth Strategists	22,415	$4.43M	1.8%	-9.3%	0.001%
11/15/2024	Geller Advisors LLC	10,081	$1.99M	0.1%	+8.3%	0.001%
11/15/2024	Hamilton Capital LLC	13,290	$2.71M	0.2%	+1.9%	0.001%
11/15/2024	Public Employees Retirement System of Ohio	815,840	$161.11M	0.7%	-0.9%	0.046%
11/15/2024	Cape Cod Five Cents Savings Bank	17,920	$3.54M	0.3%	+3.8%	0.001%
11/15/2024	Groupama Asset Managment	135,749	$27K	0.0%	+40.3%	0.008%
11/15/2024	Nomura Asset Management Co. Ltd.	1,082,758	$213.82M	0.7%	+10.6%	0.061%
11/15/2024	Raab & Moskowitz Asset Management LLC	26,514	$5.24M	1.3%	+0.3%	0.002%
11/15/2024	MML Investors Services LLC	548,661	$108.35M	0.4%	+2.2%	0.031%
11/15/2024	Hodges Capital Management Inc.	35,402	$6.99M	0.4%	-0.6%	0.002%
11/15/2024	First National Bank of Omaha	6,725	$1.33M	0.1%	-13.1%	0.000%
11/15/2024	Headinvest LLC	9,911	$1.96M	0.4%	-1.3%	0.001%
11/15/2024	Mosaic Financial Group LLC	1,166	$0.23M	0.2%	N/A	0.000%
11/15/2024	Kensington Investment Counsel LLC	30,872	$6.10M	2.5%	+1.0%	0.002%
11/15/2024	Dunhill Financial LLC	710	$0.14M	0.1%	+199.6%	0.000%
11/15/2024	Orion Portfolio Solutions LLC	137,922	$27.24M	0.6%	+1.5%	0.008%
11/15/2024	Zacks Investment Management	853,207	$168.49M	1.5%	+11.0%	0.048%
11/15/2024	Zega Financial LLC	1,470	$0.29M	0.0%	-66.4%	0.000%
11/15/2024	Zurich Insurance Group Ltd FI	376,336	$74.32M	0.6%	-23.5%	0.021%
11/15/2024	DF Dent & Co. Inc.	27,812	$5.49M	0.1%	+0.7%	0.002%
11/15/2024	National Bank of Canada FI	1,244,546	$245.77M	0.3%	+6.3%	0.070%
11/15/2024	Goldstream Capital Management Ltd	2,358	$0.47M	0.2%	N/A	0.000%
11/15/2024	Glen Eagle Advisors LLC	18,277	$3.61M	0.6%	+2.6%	0.001%

Data available starting January 2016

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Today's Range

Now: $175.58

$170.66

$176.80

50 Day Range

MA: $182.56

$164.91

$203.87

52 Week Range

Now: $175.58

$151.29

$207.32

Volume

17,695,750 shs

Average Volume

5,604,020 shs

Market Capitalization

$310.27 billion

P/E Ratio

60.97

Dividend Yield

3.54%

Beta

0.58

Who are the company insiders with the largest holdings of AbbVie?: AbbVie's top insider investors include:
Richard A Gonzalez (CEO)
Richard A Gonzalez (Chairman)
Azita Saleki-Gerhardt (EVP)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Perry C Siatis (EVP)
Scott T Reents (CFO)
Kevin K Buckbee (SVP)
Learn More about top insider investors at AbbVie.
Who are the major institutional investors of AbbVie?: AbbVie's top institutional shareholders include:
State Street Corp — 4.47%
Geode Capital Management LLC — 2.05%
Charles Schwab Investment Management Inc. — 1.35%
Franklin Resources Inc. — 0.79%
FMR LLC — 0.77%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.58%
Learn More about top institutional investors of AbbVie stock.
Which major investors are selling AbbVie stock?: In the previous quarter, ABBV stock was sold by these institutional investors:
Franklin Resources Inc.
Janus Henderson Group PLC
Wellington Management Group LLP
Charles Schwab Investment Management Inc.
Geode Capital Management LLC
Westfield Capital Management Co. LP
Artemis Investment Management LLP
Eagle Asset Management Inc.
Within the previous year, company insiders that have sold AbbVie company stock include:
Richard A Gonzalez (CEO)
Richard A Gonzalez (Chairman)
Azita Saleki-Gerhardt (EVP)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Learn More investors selling AbbVie stock.
Which major investors are buying AbbVie stock?: In the previous quarter, ABBV stock was acquired by institutional investors including:
International Assets Investment Management LLC
State Street Corp
Assenagon Asset Management S.A.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Saturna Capital Corp
FMR LLC
B. Metzler seel. Sohn & Co. Holding AG
National Pension Service